Stocks · News reference

Strata Critical Medical Raises FY2026 Sales Guidance from $260.000M-$275.000M to $285.000M-$295.000M vs $275.746M Est

Aug 4, 2026, 11:01 AMBenzinga Newsdesk

Strata Critical Medical (NASDAQ:SRTA) raises FY2026 sales outlook from $260.000 million-$275.000 million to $285.000 million-$295.000 million vs $275.746 million estimate.

Read original source More stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

SRTA

Source: benzinga
Observed: Aug 4, 2026, 11:01 AM
Checked: Aug 4, 2026, 11:01 AM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaAug 4, 2026, 12:51 PMBenzinga Insights
Strata Critical Medical Reports Q2 2026 Results: Full Earnings Call Transcript
On Tuesday, Strata Critical Medical (NASDAQ:SRTA) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For
Read original at benzinga
SRTA
SEC EDGARAug 4, 2026, 11:13 AMSEC EDGAR
8-K filing — Strata Critical Medical, Inc. (SRTA)
Filed: 2026-08-04 AccNo: 0001628280-26-052152 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Read original at edgar
SRTA
BenzingaAug 4, 2026, 11:03 AMBenzinga Newsdesk
Strata Critical Medical Q2 EPS $(0.12) Misses $(0.02) Estimate, Sales $72.506M Beat $67.112M Estimate
Read original at benzinga
SRTA

Strata Critical Medical Raises FY2026 Sales Guidance from $260.000M-$275.000M to $285.000M-$295.000M vs $275.746M Est

Connected markets

Related headlines

Strata Critical Medical Reports Q2 2026 Results: Full Earnings Call Transcript

8-K filing — Strata Critical Medical, Inc. (SRTA)

Strata Critical Medical Q2 EPS $(0.12) Misses $(0.02) Estimate, Sales $72.506M Beat $67.112M Estimate